Job Trends
In a competitive job market, how applicants present themselves in interviews is critical. Asking about promotions and expressing dislike for the work they’d be doing are just a few reasons hiring managers don’t extend job offers.
Labor Market Reports
BioSpace’s 2026 U.S. Life Sciences Employment Outlook examines the state of the biopharma workforce amid ongoing funding pressure, elevated layoffs and cautious hiring sentiment, while highlighting early signals of stabilization and cautious optimism for the year ahead.
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
Now Hiring
Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.
Looking for an IT job? From data engineer to information security, check out the BioSpace list of 10 companies hiring life sciences professionals like you.
More biopharma organizations were actively recruiting at the end of 2025 than 2024, based on the new BioSpace employment outlook report. Areas in demand this year include research and development and clinical. Organizations are also prioritizing artificial intelligence hires.
Career Advice
With leaner teams and tighter budgets, senior leaders can face tremendous strain as they juggle increased workloads and leadership responsibilities. In this column, Kaye/Bassman’s Michael Pietrack discusses how pressure builds and what can ease it.
THE LATEST
Abeona Therapeutics has plans to expand its facilities and hire an additional 25 to 40 employees.
Sangamo is moving its corporate headquarters to a new site at Oyster Point in Brisbane, CA.
The cash will allow the company to hire scientists to conduct preclinical research into a potential treatment for DMD.
A little more than one year after securing $130M in financing, molecular technology company Zymergen has expanded beyond the Golden State to the Emerald City, Seattle.
The company plans to invest nearly $10 million over five years to establish operations in Indiana.
CryoPort handles the products for more than 172 of the more than 800 immunotherapy trials underway.
Want to work for a company having a growth spurt?
New positions have been announced at Regeneron as the company’s Irish bioprocessing campus receives an additional $100m in funding.
A venture of Anhui Chem Bright Bioengineering Co. Ltd. named KB Biotech Solutions, is opening a manufacturing facility in Dillon County, SC.
Wave Life Sciences has officially opened a new state-of-the art manufacturing facility to support advancement of the company’s stereopure nucleic acid platform.